Activated T helper cell (Th cell)

Activated T helper cells, primarily characterized by the expression of the CD4 surface glycoprotein, are central coordinators of the adaptive immune response (StatPearls: NBK554481). They are activated when their T-cell receptor (TCR) recognizes specific antigenic peptides presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (NIH: Molecular Biology of the Cell). Once activated, these cells proliferate and differentiate into specialized subsets such as Th1, Th2, and Th17, which secrete distinct profiles of cytokines to direct other immune cells (PubMed: 29920506). Their biological function includes stimulating B cells to produce antibodies, activating macrophages, and recruiting neutrophils to sites of infection. In disease states, overactive T helper cells contribute to the development of autoimmune conditions like rheumatoid arthritis and multiple sclerosis, as well as chronic inflammatory diseases (Nature Reviews Immunology, 2017). Conversely, the loss or dysfunction of these cells, most notably seen in HIV/AIDS, results in severe immunodeficiency and susceptibility to opportunistic infections (NIH: NIAID). Pharmacological intervention typically involves the use of immunosuppressive drugs like calcineurin inhibitors or monoclonal antibodies that target activation markers or co-stimulatory molecules (PubChem). These therapies aim to dampen the immune response in transplant rejection or autoimmunity but carry risks of systemic immunosuppression.

Other names

CD4+ T cellHelper T lymphocyteEffector T helper cell

Inhibition of calcineurin signaling, blockade of T-cell co-stimulation, or antagonism of the IL-2 receptor.